Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.
J Immunother Cancer
; 8(2)2020 08.
Article
in En
| MEDLINE
| ID: mdl-32759235
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Proto-Oncogene Proteins B-raf
/
Oncolytic Virotherapy
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Immunother Cancer
Year:
2020
Type:
Article
Affiliation country:
United kingdom